Asahi Intecc, Eisai and Ohara were among the LPs of Africa-minded AAIC Investment’s second vehicle, following in the footsteps of corporate-backed Samurai Africa Fund 2.
Pharmaceutical firms Asahi Intecc, Eisai Corporation and Ohara Pharmaceutical Industries all committed to Africa Innovation & Healthcare Fund (AFH2), part of Singapore-based investment group AAIC Investment. Unnamed trading groups filled out the limited partners for the first close of AFH2, which is targeting a $150m final close. Its predecessor AHF1 had raised $47m in 2017,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
